New applications and developments in the use of multiplex ligation-dependent probe amplification

被引:67
作者
Kozlowski, Piotr [1 ]
Jasinska, Anna J. [2 ]
Kwiatkowski, David J. [3 ]
机构
[1] Polish Acad Sci, Inst Bioorgan Chem, Canc Genet Lab, PL-61704 Poznan, Poland
[2] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA
[3] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Translat Med,Dept Med, Boston, MA 02115 USA
关键词
Copy number variation; Expression profiling; Multiplex ligation-dependent probe amplification; Mutation detection; Transgene genotyping;
D O I
10.1002/elps.200800126
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Multiplex ligation-dependent probe amplification (MLPA) is a commonly used technique for determining relative DNA sequence dosage (or copy number) in a complex DNA sample. Originally MLPA was designed as a copy number analysis tool for detecting disease-causing genomic mutations and has been successfully applied in the testing and identification of hundreds of genomic mutations in numerous genes including DMD, BRCA1, NF1, and TSC2. More recently, several modifications of the original technique have been implemented. Arguably the most important enhancement of MLPA has been probe generation by chemical synthesis, enabling the facile creation of novel probe sets for any desired application. Other newer applications of MLPA include methylation status determination, copy number analysis in segmentally duplicated regions, expression profiling, and transgene genotyping. MLPA has a potential major role in the analysis of common copy number variation in genome-wide association analyses, which may be enhanced by future improvements to increase throughput and lower costs, such as array-MLPA.
引用
收藏
页码:4627 / 4636
页数:10
相关论文
共 86 条
[21]   Structural variants: changing the landscape of chromosomes and design of disease studies [J].
Feuk, L ;
Marshall, CR ;
Wintle, RF ;
Scherer, SW .
HUMAN MOLECULAR GENETICS, 2006, 15 :R57-R66
[22]   CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy [J].
Friedman, J. I. ;
Vrijenhoek, T. ;
Markx, S. ;
Janssen, I. M. ;
Van der Vliet, W. A. ;
Faas, B. H. W. ;
Knoers, N. V. ;
Cahn, W. ;
Kahn, R. S. ;
Edelmann, L. ;
Davis, K. L. ;
Silverman, J. M. ;
Brunner, H. G. ;
Van Kessel, A. Geurts ;
Wijmenga, C. ;
Ophoff, R. A. ;
Veltman, J. A. .
MOLECULAR PSYCHIATRY, 2008, 13 (03) :261-266
[23]   Identification of deletions and duplications of the DMD gene in affected males and carrier females by multiple ligation probe amplification (MLPA) [J].
Gatta, V ;
Scarciolla, O ;
Gaspari, AR ;
Palka, C ;
De Angelis, MV ;
Di Muzio, A ;
Guanciali-Franchi, P ;
Calabrese, G ;
Uncini, A ;
Stuppia, L .
HUMAN GENETICS, 2005, 117 (01) :92-98
[24]   Automatic analysis of multiplex ligation-dependent probe amplification products (exemplified by a commercial kit for prenatal aneuploidy detection) [J].
Gerdes, T ;
Kirchhoff, M ;
Bryndorf, T .
ELECTROPHORESIS, 2005, 26 (22) :4327-4332
[25]   Computer-assisted prenatal aneuploidy screening for chromosome 13, 18, 21, X and Y based on multiplex ligation-dependent probe amplification (MLPA) [J].
Gerdes, T ;
Kirchhoff, M ;
Lind, AM ;
Larsen, GV ;
Schwartz, M ;
Lundsteen, C .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2005, 13 (02) :171-175
[26]   The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility [J].
Gonzalez, E ;
Kulkarni, H ;
Bolivar, H ;
Mangano, A ;
Sanchez, R ;
Catano, G ;
Nibbs, RJ ;
Freedman, BI ;
Quinones, MP ;
Bamshad, MJ ;
Murthy, KK ;
Rovin, BH ;
Bradley, W ;
Clark, RA ;
Anderson, SA ;
O'Connell, RJ ;
Agan, BK ;
Ahuja, SS ;
Bologna, R ;
Sen, L ;
Dolan, MJ ;
Ahuja, SK .
SCIENCE, 2005, 307 (5714) :1434-1440
[27]   Founder mutations in the BRCA1 gene in polish families with breast-ovarian cancer [J].
Górski, B ;
Byrski, T ;
Huzarski, T ;
Jakubowska, A ;
Menkiszak, J ;
Gronwald, J ;
Pluzanska, A ;
Bebenek, M ;
Fischer-Maliszewska, L ;
Grzybowska, E ;
Narod, SA ;
Lubinski, J .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (06) :1963-1968
[28]   A high proportion of founder BRCA1 mutations in Polish breast cancer families [J].
Górski, B ;
Jakubowska, A ;
Huzarski, T ;
Byrski, T ;
Gronwald, J ;
Grzybowska, E ;
Mackiewicz, A ;
Stawicka, M ;
Bebenek, M ;
Sorokin, D ;
Fiszer-Maliszewska, L ;
Haus, O ;
Janiszewska, H ;
Niepsuj, S ;
Gózdz, S ;
Zaremba, L ;
Posmyk, M ;
Pluzanska, M ;
Kilar, E ;
Czudowska, D ;
Wasko, B ;
Miturski, R ;
Kowalczyk, JR ;
Urbanski, K ;
Szwiec, M ;
Koc, J ;
Debniak, B ;
Rozmiarek, A ;
Debniak, T ;
Cybulski, C ;
Kowalska, E ;
Toloczko-Grabarek, A ;
Zajaczek, S ;
Menkiszak, J ;
Medrek, K ;
Masojc, B ;
Mierzejewski, M ;
Narod, SA ;
Lubinski, J .
INTERNATIONAL JOURNAL OF CANCER, 2004, 110 (05) :683-686
[29]   A palindrome-driven complex rearrangement of 22q11.2 and 8q24.1 elucidated using novel technologies [J].
Gotter, Anthony L. ;
Nimmakayalu, Manjunath A. ;
Jalali, G. Reza ;
Hacker, April M. ;
Vorstman, Jacob ;
Duffy, Danielle Conforto ;
Medne, Livija ;
Emanuel, Beverly S. .
GENOME RESEARCH, 2007, 17 (04) :470-481
[30]   Deletions account for 17% of pathogenic germline alterations in MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer (HNPCC) families [J].
Grabowski, M ;
Muller-Koch, Y ;
Grasbon-Frodl, E ;
Koehler, U ;
Keller, G ;
Vogelsang, H ;
Dietmaier, W ;
Kopp, R ;
Siebers, U ;
Schmitt, W ;
Neitzel, B ;
Gruber, M ;
Doerner, C ;
Kerker, B ;
Ruemmele, P ;
Henke, G ;
Holinski-Feder, E .
GENETIC TESTING, 2005, 9 (02) :138-146